Polsinelli Podcasts - Confusion to Clarity on the Future of the 340B Program
Anti Kickback and Stark Law Enforcement and Compliance Issues
The Evolution of Informed Consent in U.S. Courts
A Moment of Simple Justice: Legal Weed
Employment Law Issues for Health Care Employers
What patients misunderstand about their right of informed consent
How is Graphene Currently Used and What is the Hope for the Future?
What is Graphene? Fenwick Patent Attorney Has the Answer
Two Tips for Inventors Filing Patent Applications
Polsinelli Podcasts - What's Happening in Healthcare Deals in 2014?
Medical Marijuana In Canada: Weeding Through the Risks and Opportunities
Tax Developments Affecting Health Care Organizations and Investor-Owned Hospital Companies
Law Prof: The Clean Air Act Needs a Reboot
Polsinelli Podcast - Health Care Payment Changes: From Service to Value
Polsinelli Podcast - Going it Alone: Factors Independent Hospitals Should Consider Before Joining a Hospital System
Polsinelli Podcast - Food Safety Modernization Act
Polsinelli Podcast - Generic Drugs to Market - What's the Climate in 2014?
Polsinelli Podcast - What's Next in Health Reform 2014
Health Care Antitrust & the Supreme Court – Interview with Bruce Sokler, Member, Mintz Levin
Polsinelli Podcast - What Employers Need to Know About Obesity in the Workplace
When one big industry sues another we learn a lot about how business as usual is conducted.
In this case Humana, a giant health insurer, has sued the medical device company Medtronic, maker of the Infuse bone graft. ...more
It is fair to say that doctors trade on their reputations more so than most other professionals. When one relies on the doctor to ensure his or her health, and occasionally save a life, the import of such a choice often...more
The bad news for 23andMe keeps coming. In late November, we learned that the U.S. Food and Drug Administration had ordered the company to stop selling its $99 DNA testing kit owing to a number of accuracy and validity...more
Things are getting worse for genetic diagnostics company 23andMe. On the heels of receiving a Warning Letter from the FDA over its Personal Genomic Services (PGS) test (see "FDA Threatens Agency Action Against 23andMe Over...more
Abbott Laboratories (Abbott), an Illinois company, will pay over $1.6 billion in penalties to the federal government and several states related to its alleged illegal promotion of the prescription drug Depakote for off-label...more
Given the power of the Internet and the unmistakable reach and shelf life of a digital complaint to hurt you, it’s more important than ever to both have and defend a professional reputation. Complaints are often...more
Find a Health Author »
Back to Top